New Platinum(II) Complexes with Chemotherapeutic Potential
Author Information
Author(s): M. B. de Oliveira, j. Miller, R. E. Banks, L. R. Kelland, C. A. McAuliffe, N. Mahmood, I. J. Rowland
Primary Institution: Federal University of Paraiba
Hypothesis
The new platinum(II) complexes MMF3 and MPF4 may exhibit anti-tumor and anti-HIV activities.
Conclusion
The new platinum(II) complexes showed some anti-cancer activity but were less potent than cis-platin and inactive against HIV.
Supporting Evidence
- The new complexes MMF3 and MPF4 were characterized by elemental analysis and NMR spectra.
- Both complexes exhibited in vitro anticancer activity against five human ovarian carcinoma cell lines.
- MMF3 and MPF4 showed cross-resistance with cis-platin in acquired resistance lines.
- The complexes were inactive against HIV compared to AZT.
Takeaway
Scientists created new platinum drugs to fight cancer and HIV, but they didn't work as well as the older drug cis-platin.
Methodology
The complexes were tested against five human ovarian carcinoma cell lines and for anti-HIV activity using specific assays.
Limitations
The new complexes were less active than cis-platin and showed cross-resistance with it in certain cancer cell lines.
Want to read the original?
Access the complete publication on the publisher's website